[1]
A. Tammaro, “Bullous pemphigoid associated with pleural mesothelioma: a controversial etiology. Were the bullous lesions induced by pembrolizumab or related to malignancy?”, JAC, vol. 40, no. 2, p. 176/179, Dec. 2022.